{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:48:35Z","timestamp":1762102115314,"version":"3.41.2"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"World Premier International Research Center Initiative"},{"DOI":"10.13039\/501100001700","name":"MEXT","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)"},{"name":"Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research","award":["26220207","26461730","17K10286"],"award-info":[{"award-number":["26220207","26461730","17K10286"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.pharep.2017.08.018","type":"journal-article","created":{"date-parts":[[2017,10,28]],"date-time":"2017-10-28T21:17:20Z","timestamp":1509225440000},"page":"350-354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effects of the delta opioid receptor agonist KNT-127 on electroencephalographic activity in mice"],"prefix":"10.1007","volume":"70","author":[{"given":"Akiyoshi","family":"Saitoh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromu","family":"Tominaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Irukayama-Tomobe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiko","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Yanagisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Nagase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2017.08.018_bib0005","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2174\/157015912803217314","article-title":"Antidepressant-like Effects of \u03b4 Opioid Receptor Agonists in Animal Models","volume":"10","author":"Saitoh","year":"2012","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.pharep.2017.08.018_bib0010","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00213-015-4195-4","article-title":"A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression","volume":"233","author":"Richards","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharep.2017.08.018_bib0015","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0022-3565(25)09569-2","article-title":"SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist","volume":"273","author":"Bilsky","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharep.2017.08.018_bib0020","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0022-3565(25)39544-3","article-title":"Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice","volume":"267","author":"Comer","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharep.2017.08.018_bib0025","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.pbb.2006.09.012","article-title":"Electroencephalographic and convulsant effects of the delta opioid agonist SNC80 in rhesus monkeys","volume":"85","author":"Danielsson","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharep.2017.08.018_bib0030","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1124\/jpet.102.036525","article-title":"Comparison of receptor mechanisms and efficacy requirements for delta-agonist-induced convulsive activity and antinociception in mice","volume":"303","author":"Broom","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharep.2017.08.018_bib0035","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1124\/jpet.105.095810","article-title":"The convulsive and electroencephalographic changes produced by nonpeptidic delta-opioid agonists in rats: comparison with pentylenetetrazol","volume":"317","author":"Jutkiewicz","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharep.2017.08.018_bib0040","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.bbr.2014.10.029","article-title":"Delta opioid receptors expressed in forebrain GABAergic neurons are responsible for SNC80-induced seizures","volume":"278","author":"Chung","year":"2015","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharep.2017.08.018_bib0045","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1248\/cpb.46.1695","article-title":"Rational drug design and synthesis of a highly selective nonpeptide delta-opioid agonist, (4aS*,12aR*)-4a-(3-hydroxyphenyl)-2-methyl- 1,2,3,4,4a,5,12,12a-octahydropyrido[3,4-b]acridine (TAN-67)","volume":"46","author":"Nagase","year":"1998","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"10.1016\/j.pharep.2017.08.018_bib0050","doi-asserted-by":"crossref","first-page":"6302","DOI":"10.1016\/j.bmcl.2010.08.083","article-title":"Design and synthesis of KNT-127, a \u03b4-opioid receptor agonist effective by systemic administration","volume":"20","author":"Nagase","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharep.2017.08.018_bib0055","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.bbr.2011.04.041","article-title":"The novel \u03b4 opioid receptor agonist KNT-127 produces antidepressant-like and antinociceptive effects in mice without producing convulsions","volume":"223","author":"Saitoh","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharep.2017.08.018_bib0060","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.neuropharm.2012.11.025","article-title":"The novel \u03b4 opioid receptor agonist KNT-127 produces distinct anxiolytic-like effects in rats without producing the adverse effects associated with benzodiazepines","volume":"67","author":"Saitoh","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharep.2017.08.018_bib0065","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1073\/pnas.0400590101","article-title":"Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice","volume":"101","author":"Mieda","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharep.2017.08.018_bib0070","doi-asserted-by":"crossref","first-page":"17949","DOI":"10.1073\/pnas.0608581103","article-title":"Lipocalin-type prostaglandin D synthase produces prostaglandin D2 involved in regulation of physiological sleep","volume":"103","author":"Qu","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharep.2017.08.018_bib0075","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.expneurol.2013.12.002","article-title":"Prostaglandin D(2) is crucial for seizure suppression and postictal sleep","volume":"253","author":"Kaushik","year":"2014","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pharep.2017.08.018_bib0080","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/nn.2132","article-title":"Seizure termination by acidosis depends on ASIC1a","volume":"11","author":"Ziemann","year":"2008","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharep.2017.08.018_bib0085","doi-asserted-by":"crossref","first-page":"5893","DOI":"10.1021\/jm8008986","article-title":"Potent, orally bioavailable delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-4-(5-hydroxyspiro[chromene-2,4'-piperidine]-4-yl)benzamide (ADL5859)","volume":"51","author":"Le Bourdonnec","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharep.2017.08.018_bib0090","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/bph.13374","article-title":"\u03b2-Arrestin 2 dependence of \u03b4 opioid receptor agonists is correlated with alcohol intake","volume":"173","author":"Chiang","year":"2016","journal-title":"Br J Pharmacol."},{"key":"10.1016\/j.pharep.2017.08.018_bib0095","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.1111\/bph.12852","article-title":"In vivo properties of KNT-127, a novel \u03b4 opioid receptor agonist: receptor internalization, antihyperalgesia and antidepressant effects in mice","volume":"171","author":"Nozaki","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharep.2017.08.018_bib0100","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1476-5381.2012.02075.x","article-title":"Evans CJ. Ligand-directed signalling within the opioid receptor family","volume":"167","author":"Pradhan","year":"2012","journal-title":"Br J Pharmacol"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114017304565?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114017304565?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:37:20Z","timestamp":1752611840000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2017.08.018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1734114017304565"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2017.08.018","relation":{},"ISSN":["1734-1140"],"issn-type":[{"type":"print","value":"1734-1140"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of the delta opioid receptor agonist KNT-127 on electroencephalographic activity in mice","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2017.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}